Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

CompletedOBSERVATIONAL
Enrollment

552

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Gastroesophageal Reflux Disease (GERD)
Trial Locations (53)

Unknown

Research Site, Leeds

Research Site, Pheonix

Research Site, Tucson

Research Site, Concord

Research Site, Lancaster

Research Site, Los Banos

Research Site, Solana Beach

Research Site, Newark

Research Site, Altamonte Springs

Research Site, Cocoa

Research Site, DeFuniak Springs

Research Site, Largo

Research Site, Maitland

Research Site, Miami

Research Site, Naples

Research Site, Ocala

Research Site, Orlando

Research Site, Palm Harbor

Research Site, Peonia

Research Site, Tampa

Research Site, Columbus

Research Site, Roswell

Research Site, Royston

Research Site, Snellville

Research Site, Belleville

Research Site, Mishawaka

Research Site, Metaire

Research Site, Prince Frederick

Research Site, Towson

Research Site, Florissant

Research Site, Jefferson City

Research Site, Atco

Research Site, Fair Lawn

Research Site, Cary

Research Site, Elkin

Research Site, New Bern

Research Site, Stanley

Research Site, Statesville

Research Site, Beachwood

Research Site, Dayton

Research Site, Vandalia

Research Site, Aliquippa

Research Site, Philadelphia

Research Site, Warwick

Research Site, Charleston

Research Site, Athens

Research Site, Austin

Research Site, Dallas

Research Site, Irving

Research Site, San Antonio

Research Site, San Marcos

Research Site, Southlake

Research Site, West Jordan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

i3 Innovus

INDUSTRY

lead

AstraZeneca

INDUSTRY